HENLOX Healthcare is a Polish company with its operating affiliate HENLOX Sp.Z.O.O headquartered in Warsaw – Poland.

HENLOX is a regional marketing company established to bridge the access gap and partner with global pharma and Nutraceutical companies to in-license and commercialize GMP approved pharmaceutics, food supplements, and other healthcare solutions into the Middle East, Asia and Africa regions.

 As such, HENLOX serves as a one-stop-solution for our partners providing multi-country access across a wide region with growing economies but complex regulations and access hurdles.

The areas of pharma generics, food supplements, vitamins and medical devices are HENLOX’s current strategic focus. The existing product portfolio was built to address unmet medical needs in the region and enabled the company not only to gain a sound market share but also to help our partners gain access to these much-needed medications.

Future expansion includes providing our own branded products through the establishment of manufacturing and development capabilities.

HENLOX’s innovative business model and efficient commercialization reach is built by successful and respected industry leaders with strong local and international track records. In addition, the HENLOX team has competencies in areas of regulatory, medical, pharmacovigilance and commercial capabilities acquired through years of experience in multinational pharma.

The team is also well-connected to a wide range of partners and key stakeholders in and out of the region, and offers a flexible approach to joint-ventures and partnerships.

This integrated and unique strategy of regional expertise coupled with strong international network, position HENLOX as the regional partner-of-choice for pharmaceutical, biotechnology and other healthcare companies seeking access to the rapidly expanding markets of Asia, Middle East & Africa.